Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,735 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Secondary Analysis of a Systematic Review: Are Antifungal Noninferiority Trials at Risk of Eroding Effectiveness Because of Biocreep?
Komorowski AS, Bai AD, Cvetkovic A, Mourad O, Lo CKL, Li XX, Mokashi V, Findlater A, Duncan DB, Fuller C, Leto DL, Yamamura D, Mertz D; McMaster Infectious Diseases Fellow Research Group. Komorowski AS, et al. Among authors: fuller c. Antimicrob Agents Chemother. 2022 Jan 18;66(1):e0162721. doi: 10.1128/AAC.01627-21. Epub 2021 Oct 18. Antimicrob Agents Chemother. 2022. PMID: 34662190 Free PMC article.
Methodological and reporting quality of non-inferiority randomized controlled trials comparing antifungal therapies: a systematic review.
Komorowski AS, Bai AD, Cvetkovic A, Mourad O, Lo CKL, Li XX, Mokashi V, Findlater A, Duncan DB, Fuller C, Yamamura D, Mertz D; McMaster Infectious Diseases Fellow Research Group. Komorowski AS, et al. Among authors: fuller c. Clin Microbiol Infect. 2022 May;28(5):640-648. doi: 10.1016/j.cmi.2021.11.003. Epub 2021 Nov 8. Clin Microbiol Infect. 2022. PMID: 34763055 Free article. Review.
Methodological and Reporting Quality of Noninferiority Randomized Controlled Trials Comparing Antiretroviral Therapies: A Systematic Review.
Lo CKL, Komorowski AS, Hall CW, Sandstrom TS, Alamer AAM, Mourad O, Li XX, Al Ohaly R, Benoit MÈ, Duncan DB, Fuller CA, Shaw S, Suresh M, Smaill F, Kapoor AK, Smieja M, Mertz D, Bai AD; McMaster Infectious Diseases Fellow Research Group. Lo CKL, et al. Clin Infect Dis. 2023 Oct 5;77(7):1023-1031. doi: 10.1093/cid/ciad308. Clin Infect Dis. 2023. PMID: 37243351
Optimized knock-in of point mutations in zebrafish using CRISPR/Cas9.
Prykhozhij SV, Fuller C, Steele SL, Veinotte CJ, Razaghi B, Robitaille JM, McMaster CR, Shlien A, Malkin D, Berman JN. Prykhozhij SV, et al. Among authors: fuller c. Nucleic Acids Res. 2018 Sep 28;46(17):9252. doi: 10.1093/nar/gky674. Nucleic Acids Res. 2018. PMID: 30053067 Free PMC article. No abstract available.
Optimized knock-in of point mutations in zebrafish using CRISPR/Cas9.
Prykhozhij SV, Fuller C, Steele SL, Veinotte CJ, Razaghi B, Robitaille JM, McMaster CR, Shlien A, Malkin D, Berman JN. Prykhozhij SV, et al. Among authors: fuller c. Nucleic Acids Res. 2018 Sep 28;46(17):e102. doi: 10.1093/nar/gky512. Nucleic Acids Res. 2018. PMID: 29905858 Free PMC article.
1,735 results